There are 2949 resources available
LBA8_PR - Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study
Presenter: Ken Kato
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA9_PR - Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study
Presenter: Ronan Kelly
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA6_PR and LBA7_PR
Presenter: Elizabeth Smyth
Session: Presidential Symposium III
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Webcast
Invited Discussant LBA8_PR and LBA9_PR
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Webcast
Welcome introduction and objectives and Treatment for locally advanced/metastatic cutaneous squamous cell carcinoma (CSCC)
Presenter: Chrysalyne Schmults
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:30-16:00
Presenter: Ana Oaknin
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Introduction
Presenter: Antonio González Martín
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Live Q&A - 24 September 2020 - 16:15-16:45
Presenter: Bradley Monk
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast